• Episode 37 - Lomustine: A Brief Overview

  • Jan 25 2023
  • Durée: 33 min
  • Podcast

Episode 37 - Lomustine: A Brief Overview

  • Résumé

  • Hello and welcome! In this episode, we go over the latest step in my current treatment and discuss what lomustine is, potential side effects, and a story of how much control some companies have over our treatments.  I'm sorry for the slight delay in releasing this episode. I've been working, going to appointments, and my voice has been pretty rough the past week or so. That makes recording just not something I could have done.  I also normalized the audio to the industry standard because I'm still learning things here! I hope it sounds ok and that the volume is balanced from start to finish with nothing being too loud or quiet. Please let me know if there are any issues.  Thank you all so much for your support and being the greatest group of people. I practice gratitude every day and it helps me so much.  Links from the show: https://chemocare.com/chemotherapy/drug-info/Lomustine.aspx https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/alkylating-agent https://www.drugs.com/drug-class/alkylating-agents.html https://cancerletter.com/trials-and-tribulations/20210716_7/ https://www.cbsnews.com/news/brain-cancer-drug-gleostine-no-longer-an-option-under-medicare/ https://journals.lww.com/neurotodayonline/fulltext/2021/09160/a_glioblastoma_drug_is_abruptly_withdrawn_from.6.aspx

    Voir plus Voir moins

Ce que les auditeurs disent de Episode 37 - Lomustine: A Brief Overview

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.